HYPERION DEFI, INC. Increase Decrease In Operating Lease Liability
HYPERION DEFI, INC. (HYPD) reported Increase Decrease In Operating Lease Liability of -$245.37 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- HYPERION DEFI, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$124.43K.
- HYPERION DEFI, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$120.94K.
- HYPERION DEFI, INC. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$117.83K.
- HYPERION DEFI, INC. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$114.42K.
- HYPERION DEFI, INC. increase decrease in operating lease liability for fiscal 2025 was -$574.06K.
- HYPERION DEFI, INC. increase decrease in operating lease liability for fiscal 2024 was -$501.25K.
- HYPERION DEFI, INC. increase decrease in operating lease liability for fiscal 2023 was -$503.05K.
- HYPERION DEFI, INC. increase decrease in operating lease liability for fiscal 2022 was -$412.48K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$124.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$245.37K 10-Q · filed 2026-08-13 | -$363.19K derived: sum of 3 quarters · filed 2026-08-13 | -$477.61K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$120.94K 10-Q · filed 2026-05-15 | -$238.76K derived: sum of 2 quarters · filed 2026-05-15 | -$353.18K derived: sum of 3 quarters · filed 2026-05-15 | -$542.56K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$117.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$232.24K derived: sum of 2 quarters · filed 2026-03-30 | -$421.62K derived: sum of 3 quarters · filed 2026-08-13 | -$574.06K 10-K · filed 2026-03-30 |
| 2025-09-30 | -$114.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$303.80K derived: sum of 2 quarters · filed 2026-08-13 | -$456.23K 10-Q · filed 2025-11-14 | -$604.65K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$189.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$341.82K 10-Q · filed 2026-08-13 | -$490.23K derived: sum of 3 quarters · filed 2026-08-13 | -$633.37K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$152.44K 10-Q · filed 2026-05-15 | -$300.85K derived: sum of 2 quarters · filed 2026-05-15 | -$443.99K derived: sum of 3 quarters · filed 2026-05-15 | -$579.59K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$148.41K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$291.55K derived: sum of 2 quarters · filed 2026-03-30 | -$427.15K derived: sum of 3 quarters · filed 2026-03-30 | -$501.25K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$143.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$278.74K derived: sum of 2 quarters · filed 2025-11-14 | -$352.84K 10-Q · filed 2025-11-14 | -$444.62K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$135.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$209.70K 10-Q · filed 2025-08-13 | -$301.48K derived: sum of 3 quarters · filed 2025-08-13 | -$427.75K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$74.10K 10-Q · filed 2025-05-19 | -$165.88K derived: sum of 2 quarters · filed 2025-05-19 | -$292.15K derived: sum of 3 quarters · filed 2025-05-19 | -$441.00K derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | -$91.78K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$218.05K derived: sum of 2 quarters · filed 2025-04-15 | -$366.90K derived: sum of 3 quarters · filed 2025-04-15 | -$503.05K 10-K · filed 2025-04-15 |
| 2023-09-30 | -$126.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$275.12K derived: sum of 2 quarters · filed 2024-11-12 | -$411.27K 10-Q · filed 2024-11-12 | -$874.65K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$148.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$285.00K 10-Q · filed 2024-08-14 | -$748.38K derived: sum of 3 quarters · filed 2024-08-14 | -$699.83K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$136.15K 10-Q · filed 2024-05-15 | -$599.53K derived: sum of 2 quarters · filed 2024-05-15 | -$550.98K derived: sum of 3 quarters · filed 2024-05-15 | -$459.14K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$463.38K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | -$414.83K derived: sum of 2 quarters · filed 2024-03-18 | -$322.99K derived: sum of 3 quarters · filed 2024-03-18 | -$412.48K 10-K · filed 2024-03-18 |
| 2022-09-30 | $48.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $140.40K derived: sum of 2 quarters · filed 2023-11-13 | $50.91K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $91.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $2.36K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | -$89.49K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |